“Online Promotion in 2012” is an essential report for any pharma company evaluating their approach to online promotional programs for 2013. Key attributes of the report include:
Companies covered in the report include: Abbott, Alcon, Amylin, Allergan, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Covidien, Eli Lilly, Endo, Forest Laboratories, Galderma, GE Healthcare, Genzyme, Genentech, Gilead, GlaxoSmithKline, Janssen, Johnson & Johnson, Medtronic, Merck, Novartis, Novo Nordisk, Pfizer, Roche, Shire, Stryker, Sunovion, Salix, Takeda, Teva, UCB, Vertex, and Watson.
“Physicians show strong demand for online promotional programs,” said James Avallone, Principal Analyst. “However, physicians are a discerning audience with high expectations for these programs. In order to optimize online promotion campaigns, pharma must commit to sustained and adequate investments in this channel.”